Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease.

Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease. — المؤلف: Holdstock, Louis — Clinical kidney journal Feb 2019

المؤلف
Holdstock, Louis
النشر
Clinical kidney journal Feb 2019
الوصف
129-138 p.